VTAMA

Dermavant Sciences, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 22, 2023
Approval ID: 9309d20f-8cd4-4c96-93fa-7f730e83c7ab
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VTAMA cream safely and effectively. See full prescribing information for VTAMA. VTAMA (tapinarof) cream, 1%, for topical use. Initial U.S. Approval: 2022

Quick Stats

Total Products1

Labelers2

Label Sections15

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.